Promus Capital, LLC Ishares Biotechnology ETF Transaction History

Promus Capital, LLC

$106 Billion
Q4 2024

A detailed history of Promus Capital, LLC transactions in Ishares Biotechnology ETF stock. As of the latest transaction made, Promus Capital, LLC holds 136 shares of IBB stock, worth $18,992. This represents 0.02% of its overall portfolio holdings.

Number of Shares

136

Holding current value

$18,992

% of portfolio

0.02%

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Feb 06, 2025	BUY	$131.21 - $148.85 $17,844 - $20,243	136 New	136 $18 Million

Others Institutions Holding IBB

# of Institutions

1,000

Shares Held

34.2M

Call Options Held

Put Options Held

6.48M

Bank Of America Corp Charlotte, NC

7.15M
Shares

$999 Million
0.09% of portfolio
Morgan Stanley New York, NY

3.16M
Shares

$441 Million
0.03% of portfolio
Citigroup Inc

1.98M
Shares

$276 Million
0.17% of portfolio
Royal Bank Of Canada Toronto, A6

1.47M
Shares

$206 Million
0.05% of portfolio
Jane Street Group, LLC New York, NY

1.44M
Shares

$201 Million
0.05% of portfolio

View Full List

About ISHARES BIOTECHNOLOGY ETF

Ticker IBB
Sector ETFs
Industry ETFs

More about IBB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Promus Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Promus Capital, LLC with notifications on news.

Account